GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a remarkable development in how we approach type 2 diabetes . These injectable therapies function to imitating the body’s natural https://companyspage.com/story6716245/glp-1-a-significant-approach-in-glucose-care